Phoebe Hildreth Yager, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intensive Care Units, Pediatric | 17 | 2024 | 1021 | 3.370 |
Why?
|
Telemedicine | 8 | 2020 | 3111 | 0.940 |
Why?
|
Teaching Rounds | 2 | 2020 | 280 | 0.910 |
Why?
|
Quality Improvement | 4 | 2024 | 3850 | 0.870 |
Why?
|
Critical Care | 7 | 2023 | 2714 | 0.850 |
Why?
|
Intubation, Intratracheal | 4 | 2024 | 1359 | 0.730 |
Why?
|
Hyperkalemia | 2 | 2021 | 233 | 0.700 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 116 | 0.650 |
Why?
|
Professional-Family Relations | 2 | 2020 | 500 | 0.620 |
Why?
|
Naloxone | 1 | 2021 | 372 | 0.610 |
Why?
|
Hyponatremia | 1 | 2021 | 278 | 0.600 |
Why?
|
Respiration, Artificial | 4 | 2024 | 2727 | 0.590 |
Why?
|
Hospitals, Pediatric | 4 | 2023 | 1851 | 0.590 |
Why?
|
Intracranial Pressure | 1 | 2020 | 323 | 0.580 |
Why?
|
Intracranial Hypertension | 1 | 2020 | 191 | 0.570 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 384 | 0.550 |
Why?
|
Emergency Medicine | 3 | 2017 | 1220 | 0.540 |
Why?
|
Hospital Rapid Response Team | 1 | 2016 | 54 | 0.500 |
Why?
|
Videoconferencing | 1 | 2017 | 209 | 0.470 |
Why?
|
Documentation | 1 | 2021 | 914 | 0.470 |
Why?
|
Sodium | 1 | 2020 | 1594 | 0.470 |
Why?
|
Heparin | 1 | 2022 | 1636 | 0.460 |
Why?
|
Manikins | 2 | 2017 | 255 | 0.460 |
Why?
|
Patient Care Team | 6 | 2020 | 2519 | 0.460 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2014 | 59 | 0.450 |
Why?
|
Babesia microti | 1 | 2014 | 31 | 0.440 |
Why?
|
Child | 33 | 2024 | 80670 | 0.420 |
Why?
|
Babesiosis | 1 | 2014 | 92 | 0.410 |
Why?
|
Tachycardia, Ventricular | 1 | 2021 | 1313 | 0.400 |
Why?
|
Pediatrics | 5 | 2020 | 3614 | 0.400 |
Why?
|
After-Hours Care | 1 | 2012 | 102 | 0.380 |
Why?
|
Blood | 1 | 2014 | 598 | 0.370 |
Why?
|
Intensive Care Units | 3 | 2023 | 3799 | 0.370 |
Why?
|
Neurologic Examination | 1 | 2014 | 913 | 0.370 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 210 | 0.340 |
Why?
|
Shock | 2 | 2021 | 316 | 0.330 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3927 | 0.320 |
Why?
|
Infant | 16 | 2024 | 36459 | 0.310 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2596 | 0.300 |
Why?
|
Physical Examination | 1 | 2014 | 1265 | 0.300 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2022 | 621 | 0.290 |
Why?
|
Mannose-Binding Lectin | 1 | 2008 | 146 | 0.270 |
Why?
|
Child, Preschool | 15 | 2024 | 42577 | 0.270 |
Why?
|
Thromboembolism | 1 | 2012 | 1003 | 0.260 |
Why?
|
Airway Management | 3 | 2021 | 325 | 0.250 |
Why?
|
Curriculum | 4 | 2024 | 3783 | 0.250 |
Why?
|
Anemia | 1 | 2014 | 1514 | 0.230 |
Why?
|
Parents | 2 | 2019 | 3592 | 0.220 |
Why?
|
Electronic Health Records | 1 | 2021 | 4880 | 0.220 |
Why?
|
Multilingualism | 1 | 2024 | 88 | 0.210 |
Why?
|
Boston | 5 | 2020 | 9346 | 0.210 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2228 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.200 |
Why?
|
Child Mortality | 1 | 2024 | 204 | 0.200 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1043 | 0.180 |
Why?
|
Cities | 1 | 2023 | 542 | 0.180 |
Why?
|
Humans | 46 | 2024 | 766812 | 0.180 |
Why?
|
Physicians | 1 | 2019 | 4591 | 0.180 |
Why?
|
Waste Management | 1 | 2020 | 19 | 0.180 |
Why?
|
Tracheostomy | 1 | 2024 | 430 | 0.170 |
Why?
|
Otolaryngology | 2 | 2020 | 699 | 0.170 |
Why?
|
Respiratory System | 2 | 2020 | 562 | 0.170 |
Why?
|
Organizational Policy | 2 | 2020 | 434 | 0.170 |
Why?
|
Adolescent | 14 | 2024 | 88902 | 0.160 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 116 | 0.160 |
Why?
|
Bioethical Issues | 1 | 2020 | 119 | 0.160 |
Why?
|
Developing Countries | 3 | 2024 | 2912 | 0.160 |
Why?
|
Brain Injuries | 2 | 2008 | 2053 | 0.160 |
Why?
|
Containment of Biohazards | 1 | 2019 | 39 | 0.160 |
Why?
|
Bioethics | 1 | 2020 | 118 | 0.160 |
Why?
|
Critical Illness | 4 | 2022 | 2750 | 0.150 |
Why?
|
Dexmedetomidine | 2 | 2014 | 321 | 0.150 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 168 | 0.150 |
Why?
|
Male | 22 | 2024 | 364154 | 0.140 |
Why?
|
Inservice Training | 1 | 2019 | 374 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 668 | 0.130 |
Why?
|
Outsourced Services | 1 | 2016 | 20 | 0.130 |
Why?
|
Hospital Administration | 1 | 2020 | 351 | 0.130 |
Why?
|
Angiography | 1 | 2022 | 1595 | 0.130 |
Why?
|
Narcotic Antagonists | 1 | 2021 | 591 | 0.130 |
Why?
|
Female | 20 | 2024 | 396532 | 0.130 |
Why?
|
Rabies Vaccines | 1 | 2015 | 29 | 0.120 |
Why?
|
Transportation of Patients | 1 | 2016 | 177 | 0.120 |
Why?
|
Rabies virus | 1 | 2015 | 37 | 0.120 |
Why?
|
Respiratory Therapy | 1 | 2015 | 124 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2019 | 495 | 0.120 |
Why?
|
Rabies | 1 | 2015 | 56 | 0.120 |
Why?
|
Postoperative Care | 2 | 2011 | 1480 | 0.120 |
Why?
|
Hypnotics and Sedatives | 2 | 2014 | 1193 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1408 | 0.110 |
Why?
|
Environment | 1 | 2020 | 1120 | 0.110 |
Why?
|
Tick-Borne Diseases | 1 | 2014 | 37 | 0.110 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2019 | 424 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1512 | 0.100 |
Why?
|
Dysarthria | 1 | 2012 | 57 | 0.100 |
Why?
|
Caregivers | 1 | 2024 | 2303 | 0.100 |
Why?
|
Hypokalemia | 1 | 2013 | 152 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2158 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2022 | 81657 | 0.100 |
Why?
|
Basilar Artery | 1 | 2012 | 207 | 0.100 |
Why?
|
Patient Transfer | 2 | 2016 | 789 | 0.090 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 695 | 0.090 |
Why?
|
Infection Control | 1 | 2019 | 984 | 0.090 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5367 | 0.090 |
Why?
|
Brain Death | 2 | 2012 | 360 | 0.090 |
Why?
|
Communication | 2 | 2017 | 3905 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 652 | 0.090 |
Why?
|
Hypovolemia | 1 | 2010 | 48 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1481 | 0.090 |
Why?
|
Homocystinuria | 1 | 2010 | 65 | 0.090 |
Why?
|
Stroke | 1 | 2012 | 9744 | 0.090 |
Why?
|
Ataxia | 1 | 2012 | 307 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2143 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 834 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2019 | 1761 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4626 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2566 | 0.080 |
Why?
|
Patient Simulation | 1 | 2011 | 300 | 0.080 |
Why?
|
Liver Failure, Acute | 1 | 2010 | 182 | 0.080 |
Why?
|
Coma | 1 | 2012 | 485 | 0.080 |
Why?
|
Pilot Projects | 3 | 2017 | 8728 | 0.080 |
Why?
|
Adult | 7 | 2023 | 223305 | 0.080 |
Why?
|
Hospitalists | 1 | 2012 | 297 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 996 | 0.080 |
Why?
|
Observer Variation | 1 | 2014 | 2614 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12985 | 0.070 |
Why?
|
Death | 1 | 2012 | 685 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14762 | 0.070 |
Why?
|
Problem-Based Learning | 1 | 2011 | 360 | 0.070 |
Why?
|
Leukoencephalopathies | 1 | 2010 | 258 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2513 | 0.070 |
Why?
|
Complement C4 | 1 | 2007 | 216 | 0.070 |
Why?
|
Brain Edema | 2 | 2008 | 601 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 587 | 0.070 |
Why?
|
Fever | 1 | 2014 | 1607 | 0.070 |
Why?
|
Larynx | 1 | 2010 | 492 | 0.060 |
Why?
|
Complement C3 | 1 | 2008 | 434 | 0.060 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 744 | 0.060 |
Why?
|
Complement Activation | 1 | 2008 | 447 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2017 | 5306 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39312 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 932 | 0.060 |
Why?
|
Skin Diseases | 1 | 2014 | 1084 | 0.060 |
Why?
|
Vision Disorders | 1 | 2012 | 1090 | 0.060 |
Why?
|
Prospective Studies | 5 | 2017 | 54872 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15912 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2010 | 709 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3485 | 0.060 |
Why?
|
Checklist | 1 | 2011 | 841 | 0.060 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 987 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 441 | 0.060 |
Why?
|
Shock, Septic | 1 | 2010 | 772 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8734 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3213 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1217 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1540 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2015 | 2416 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2020 | 26387 | 0.050 |
Why?
|
Heart Rate | 1 | 2014 | 4207 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 1988 | 641 | 0.050 |
Why?
|
Cell Death | 1 | 2008 | 1676 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2783 | 0.050 |
Why?
|
Acute Disease | 1 | 2012 | 7240 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6968 | 0.050 |
Why?
|
United States | 6 | 2024 | 72945 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2015 | 3306 | 0.050 |
Why?
|
Recycling | 1 | 2020 | 16 | 0.040 |
Why?
|
Medical Waste | 1 | 2020 | 16 | 0.040 |
Why?
|
Disease Management | 1 | 2011 | 2533 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7870 | 0.040 |
Why?
|
Communication Barriers | 1 | 2024 | 418 | 0.040 |
Why?
|
Blood Pressure | 2 | 2014 | 8533 | 0.040 |
Why?
|
Equipment Reuse | 1 | 2020 | 45 | 0.040 |
Why?
|
Movement | 1 | 2007 | 1468 | 0.040 |
Why?
|
El Salvador | 1 | 2019 | 34 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4278 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2604 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20146 | 0.040 |
Why?
|
Anesthesia | 1 | 2010 | 1595 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1733 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 59939 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3001 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14653 | 0.040 |
Why?
|
Africa, Western | 1 | 2019 | 160 | 0.040 |
Why?
|
Patient Isolation | 1 | 2019 | 101 | 0.040 |
Why?
|
Home Care Services | 1 | 2024 | 659 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6258 | 0.040 |
Why?
|
Recovery of Function | 1 | 2008 | 2978 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 548 | 0.040 |
Why?
|
Regional Medical Programs | 1 | 2016 | 64 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2140 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2008 | 14473 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2869 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2191 | 0.030 |
Why?
|
Ecuador | 1 | 2014 | 62 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 74889 | 0.030 |
Why?
|
Video Recording | 1 | 2019 | 977 | 0.030 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2015 | 113 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2015 | 292 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 337 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1972 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7430 | 0.030 |
Why?
|
Educational Measurement | 1 | 2019 | 1259 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3430 | 0.020 |
Why?
|
Patient Discharge | 1 | 2024 | 3466 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6306 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 713 | 0.020 |
Why?
|
Tissue Donors | 2 | 2015 | 2392 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2015 | 609 | 0.020 |
Why?
|
Clinical Competence | 2 | 2019 | 4858 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2012 | 285 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2846 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4056 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14073 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8540 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2662 | 0.020 |
Why?
|
Alamethicin | 1 | 1988 | 2 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1654 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2024 | 4526 | 0.020 |
Why?
|
Patient Admission | 1 | 2016 | 1364 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8890 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2015 | 858 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18329 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41706 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1988 | 405 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3640 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 1988 | 376 | 0.020 |
Why?
|
Postoperative Period | 1 | 2011 | 1824 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13276 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65286 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4853 | 0.020 |
Why?
|
Electrodes | 1 | 1988 | 612 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10580 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 18076 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 703 | 0.020 |
Why?
|
Safety Management | 1 | 2011 | 765 | 0.020 |
Why?
|
Surface Properties | 1 | 1988 | 1153 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2504 | 0.020 |
Why?
|
Maze Learning | 1 | 2007 | 479 | 0.020 |
Why?
|
Calcium Channels | 1 | 1988 | 622 | 0.010 |
Why?
|
Registries | 1 | 2020 | 8352 | 0.010 |
Why?
|
Mice | 2 | 2008 | 81898 | 0.010 |
Why?
|
Health Personnel | 1 | 2017 | 3384 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3618 | 0.010 |
Why?
|
Cattle | 1 | 1988 | 3815 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40149 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21527 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10745 | 0.010 |
Why?
|
Ligands | 1 | 1988 | 3274 | 0.010 |
Why?
|
Animals | 3 | 2008 | 168939 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1154 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10816 | 0.010 |
Why?
|
Equipment Design | 1 | 1988 | 3488 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4570 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1838 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6491 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2815 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1885 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 223267 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11062 | 0.010 |
Why?
|
Inflammation | 1 | 2007 | 10863 | 0.000 |
Why?
|